Literature DB >> 18695651

The other causality question: estimating attributable fractions for obesity as a cause of mortality.

B J Levine1.   

Abstract

Recent scientific controversy over the accuracy of population attributable fraction (PAF) estimates for obesity as a cause of mortality has made the concept of PAF visible in both scientific and popular news. The PAF is widely thought to provide information about causation, or attribution, of disease and also to provide information on the consequences of interventions to eliminate the exposure of interest. I discuss the methodological and conceptual limitations of the PAF in providing these two kinds of information. Because of these limitations, the PAF does not provide scientists or policy makers with an accurate answer to the question, How much of the disease burden could be eliminated if the exposure was eliminated from the population? Further, these limitations cannot be overcome merely by better statistical modeling; they must be addressed through more rigorous discussion of specific interventions and the causal consequences of such interventions.

Entities:  

Mesh:

Year:  2008        PMID: 18695651     DOI: 10.1038/ijo.2008.81

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  10 in total

1.  Disparities among US states in HIV-related mortality in persons with HIV infection, 2001-2007.

Authors:  David B Hanna; Richard M Selik; Tian Tang; Stephen J Gange
Journal:  AIDS       Date:  2012-01-02       Impact factor: 4.177

2.  Cost-of-illness studies: a guide to critical evaluation.

Authors:  Allison Larg; John R Moss
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

3.  Percentage of gestational diabetes mellitus attributable to overweight and obesity.

Authors:  Shin Y Kim; Lucinda England; Hoyt G Wilson; Connie Bish; Glen A Satten; Patricia Dietz
Journal:  Am J Public Health       Date:  2010-04-15       Impact factor: 9.308

4.  Association of maternal body mass index, excessive weight gain, and gestational diabetes mellitus with large-for-gestational-age births.

Authors:  Shin Y Kim; Andrea J Sharma; William Sappenfield; Hoyt G Wilson; Hamisu M Salihu
Journal:  Obstet Gynecol       Date:  2014-04       Impact factor: 7.661

5.  Are gestational diabetes mellitus and preconception diabetes mellitus less common in non-Hispanic black women than in non-Hispanic white women?

Authors:  Catherine Kim; Shin Y Kim; William Sappenfield; Hoyt G Wilson; Hamisu M Salihu; Andrea J Sharma
Journal:  Matern Child Health J       Date:  2014-04

6.  Preventing large birth size in women with preexisting diabetes mellitus: The benefit of appropriate gestational weight gain.

Authors:  Shin Y Kim; Andrea J Sharma; William Sappenfield; Hamisu M Salihu
Journal:  Prev Med       Date:  2016-08-16       Impact factor: 4.018

7.  Life-course BMI and biomarkers in persons aged 60 years or older: a comparison of the USA and Costa Rica.

Authors:  David H Rehkopf; Andrew Duong; William H Dow; Luis Rosero-Bixby
Journal:  Public Health Nutr       Date:  2018-10-11       Impact factor: 4.022

8.  Fraction of gestational diabetes mellitus attributable to overweight and obesity by race/ethnicity, California, 2007-2009.

Authors:  Shin Y Kim; Carina Saraiva; Michael Curtis; Hoyt G Wilson; Jennifer Troyan; Andrea J Sharma
Journal:  Am J Public Health       Date:  2013-08-15       Impact factor: 9.308

9.  Racial/ethnic differences in the percentage of gestational diabetes mellitus cases attributable to overweight and obesity, Florida, 2004-2007.

Authors:  Shin Y Kim; Lucinda England; William Sappenfield; Hoyt G Wilson; Connie L Bish; Hamisu M Salihu; Andrea J Sharma
Journal:  Prev Chronic Dis       Date:  2012-04-19       Impact factor: 2.830

10.  Mortality Attributable to Excess Body Mass Index in Iran: Implementation of the Comparative Risk Assessment Methodology.

Authors:  Shirin Djalalinia; Sahar Saeedi Moghaddam; Niloofar Peykari; Amir Kasaeian; Ali Sheidaei; Anita Mansouri; Younes Mohammadi; Mahboubeh Parsaeian; Parinaz Mehdipour; Bagher Larijani; Farshad Farzadfar
Journal:  Int J Prev Med       Date:  2015-11-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.